This is the comparison most sites get wrong — usually by trashing prescription drugs to sell supplements. Here's the truth up front: BPH medications work. They're FDA-approved, tested in large trials, and help most men who take them. The honest questions are about trade-offs: side effects, speed, cost, and whether your symptoms are mild enough that a gentler option is worth trying first. That's what this guide covers.

📊 Severity should drive this decision. Take the free 2-minute IPSS symptom score — it's the same index your urologist would use, and the ranges below reference it.

What Each Prescription Class Actually Does

Alpha-blockers (tamsulosin/Flomax, alfuzosin, silodosin) relax the smooth muscle of the prostate and bladder neck, improving flow within days. They don't change the prostate itself — stop the pill, symptoms return. Their documented side effects include dizziness on standing, retrograde ejaculation, and headache; they also matter before cataract surgery (floppy iris syndrome). We cover this class in depth in our Flomax guide.

5-alpha reductase inhibitors (finasteride, dutasteride) block conversion of testosterone to DHT, which actually shrinks the prostate over 3–6 months — the only pills that do. The trade-offs on the label: sexual side effects and reduced libido in a meaningful minority of men, and they roughly halve PSA readings (your doctor must adjust cancer-screening interpretation). For larger prostates with progressive symptoms, they're often the right call.

Combination therapy (an alpha-blocker plus a 5-ARI) outperformed either drug alone for men with larger prostates in the landmark MTOPS trial — the standard approach for moderate-to-severe cases at risk of progression.

What ProstaVive Can and Can't Do

ProstaVive is a supplement, not a drug. Its formula centers on circulation-supporting ingredients (boron, L-citrulline, maca) plus zinc and vitamin D — a different mechanism from both prescription classes and from the usual DHT-blocking botanicals. We break down the research behind each ingredient in our ingredient analysis.

• It can: be tried without a prescription, with a gentler documented side-effect profile and a 180-day refund window that covers the full evaluation period.
• It can't: shrink your prostate, match the trial evidence of FDA-approved drugs, or substitute for medical care in moderate-to-severe disease.
• Nobody can promise it will work for you. Supplement response varies; a meaningful share of men see no benefit — which is exactly why the refund window is the feature we weight most.

The Decision Framework

Final Verdict

For mild-to-moderate symptoms in men not yet on medication, an 8–12 week ProstaVive trial is a reasonable conservative first step: low documented risk, no prescription, and a refund window long enough to judge honestly — track your IPSS score before and after. For moderate-to-severe symptoms, prescription medication under a doctor's care is the evidence-backed choice, and supplements are at most a complement. That's the honest answer — anyone telling you a supplement replaces medical treatment is selling, not informing.

This article is for informational purposes only and is not medical advice. Statements about supplements have not been evaluated by the FDA. Products mentioned are not intended to diagnose, treat, cure, or prevent any disease.